Question from Deputy Ken O'Flynn - PQ 10655-26
Deputy O'Flynn asked about the use of GLP-1 receptor agonist medicines for obesity or weight management. Read the HSE response.
- Published date:
- :
Browse and read HSE's latest publications, which include strategic plans, reports, official policies and codes, Parliamentary Question (PQ) responses, and board meeting minutes.
Deputy O'Flynn asked about the use of GLP-1 receptor agonist medicines for obesity or weight management. Read the HSE response.
Deputy O'Flynn asked whether the HSE has completed a formal evaluation for tirzepatide (mounjaro) and semaglutide (wegovy) for obesity or weight management.
Deputy Byrne asked about the waiting list for a first outpatient appointment at Our Lady of Lourdes Hospital, Drogheda. Read the HSE response.
Deputy Byrne asked about the waiting list orthopaedic procedures in Our Lady of Lourdes Hospital, Drogheda. Read the HSE response.
Deputy Byrne asked about the the number of persons in Louth waiting for disability services outside CDNTs. Read the HSE response.
Deputy Cronin asked about the number of adults and children currently on waiting lists for public dental services in Kildare. Read the HSE response.
Deputy Cullinane asked why pluvicto was not approved for reimbursement but luthathera received approval. Read the HSE response.
Deputy Byrne asked about the ENT (ear, nose and throat) outpatient appointments waiting list for Our Lady of Lourdes Hospital, Drogheda. Read the HSE response.
Deputy Byrne asked for the bed occupancy rates at Our Lady of Lourdes Hospital, Drogheda. Read the HSE response.
Deputy Brabazon asked if cataract surgeries will be carried out at the new Dublin North HSE surgical hub. Read the HSE response.